All products are for research purposes only, not for human consumption.
Stay informed with latest scientific research, studies, and more!
As we approach the end of 2025, the research peptide landscape continues to evolve rapidly, driven by breakthroughs in metabolic health, tissue regeneration, mitochondrial function, and anti-aging science. This comprehensive guide explores the most promising research peptides, common stacking strategies, and important safety considerations.
Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist research peptide, continues to drive extensive investigation in metabolic and cardiovascular research models. As a synthetic analog mimicking endogenous GLP-1, semaglutide has been studied for its potential to influence glucose homeostasis, weight regulation, and related pathways in preclinical and clinical trial settings.
Tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist research peptide, has garnered attention for its multimodal effects on metabolic pathways.
Retatrutide, an investigational triple agonist targeting GLP-1, GIP, and glucagon receptors, represents a frontier in metabolic peptide research. This synthetic peptide's balanced receptor activation promises amplified effects on energy balance and lipid metabolism in preclinical models.
TB-500, the synthetic version of thymosin beta-4 (Tβ4), a 43-amino acid peptide, is researched for actin sequestration and tissue repair modulation. This post reviews 2024-2025 findings from PubMed-indexed studies at the University of Texas and Regeneron Pharmaceuticals, emphasizing preclinical wound and fibrosis models.
BPC-157, a 15-amino acid gastric pentadecapeptide, is researched for cytoprotective and angiogenic properties in musculoskeletal models. This summary draws from University of Zagreb and Pliva Croatia trials.
Ipamorelin, a selective ghrelin mimetic pentapeptide, targets GHSR for pulsatile GH release in neuroendocrine research. From Novo Nordisk and University of Copenhagen labs.
Sermorelin, a 29-amino acid GHRH analog, stimulates endogenous GH secretion in aging and deficiency models. Research from Gerontology Research Center and Endocrine Society.
CJC-1295, a tetrasubstituted GHRH(1-29) analog with Drug Affinity Complex (DAC), provides sustained GH elevation in metabolic and body composition studies.
NAD+ (nicotinamide adenine dinucleotide), while technically a coenzyme, is researched alongside peptides for cellular energy, DNA repair, and longevity pathways.
PT-141, a cyclic heptapeptide melanocortin receptor agonist, is researched for central nervous system effects on arousal and related pathways.
GHK-Cu, a naturally occurring copper-binding tripeptide, is researched for wound healing, collagen synthesis, and anti-aging skin effects.
Epitalon (Epithalon), a tetrapeptide (Ala-Glu-Asp-Gly), is researched for telomerase activation and potential longevity effects in aging models.